Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
24.23
-1.27 (-4.98%)
At close: Apr 28, 2026, 4:00 PM EDT
24.23
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Damora Therapeutics Employees
Damora Therapeutics had 7 employees as of December 31, 2025. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$29,977,000
Market Cap
1.46B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Immatics | 711 |
| Agios Pharmaceuticals | 540 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| Precigen | 160 |
DMRA News
- 4 weeks ago - Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors - GlobeNewsWire
- 5 weeks ago - Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 7 weeks ago - Damora Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million - GlobeNewsWire
- 2 months ago - Galecto Announces Pricing of $275 Million Underwritten Public Offering - GlobeNewsWire
- 4 months ago - Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - GLTO, MOVE: two penny stocks quadrupled today – but should you buy? - Invezz